ArticleBMC bioinformatics2022
CARE 2.0: reducing false-positive sequencing error corrections using machine learning.
Article in BMC bioinformatics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed, 16 citations in OpenAlex.
- Current perspectives and challenges of using artificial intelligence in immunodeficiencies.The Journal of allergy and clinical immunology · 2025Review
- How error correction affects polymerase chain reaction deduplication: A survey based on unique molecular identifier datasets of short reads.Quantitative biology (Beijing, China) · 2025Review
- Enhancing Clinical Applications by Evaluation of Sensitivity and Specificity in Whole Exome Sequencing.International journal of molecular sciences · 2024Article
- A survey of k-mer methods and applications in bioinformatics.Computational and structural biotechnology journal · 2024Review
- CAREx: context-aware read extension of paired-end sequencing data.BMC bioinformatics · 2024Article
- MAC-ErrorReads: machine learning-assisted classifier for filtering erroneous NGS reads.BMC bioinformatics · 2024Article
- Illumina reads correction: evaluation and improvements.Scientific reports · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundNext-generation sequencing pipelines often perform error correction as a preprocessing step to obtain cleaned input data. State-of-the-art error correction programs are able to reliably detect and correct the majority of sequencing errors. However, they also introduce new errors by making false-positive corrections. These correction mistakes can have negative impact on downstream analysis, such as k-mer statistics, de-novo assembly, and variant calling. This motivates the need for more precise error correction tools.
resultsWe present CARE 2.0, a context-aware read error correction tool based on multiple sequence alignment targeting Illumina datasets. In addition to a number of newly introduced optimizations its most significant change is the replacement of CARE 1.0's hand-crafted correction conditions with a novel classifier based on random decision forests trained on Illumina data. This results in up to two orders-of-magnitude fewer false-positive corrections compared to other state-of-the-art error correction software. At the same time, CARE 2.0 is able to achieve high numbers of true-positive corrections comparable to its competitors. On a simulated full human dataset with 914M reads CARE 2.0 generates only 1.2M false positives (FPs) (and 801.4M true positives (TPs)) at a highly competitive runtime while the best corrections achieved by other state-of-the-art tools contain at least 3.9M FPs and at most 814.5M TPs. Better de-novo assembly and improved k-mer analysis show the applicability of CARE 2.0 to real-world data.
conclusionFalse-positive corrections can negatively influence down-stream analysis. The precision of CARE 2.0 greatly reduces the number of those corrections compared to other state-of-the-art programs including BFC, Karect, Musket, Bcool, SGA, and Lighter. Thus, higher-quality datasets are produced which improve k-mer analysis and de-novo assembly in real-world datasets which demonstrates the applicability of machine learning techniques in the context of sequencing read error correction. CARE 2.0 is written in C++/CUDA for Linux systems and can be run on the CPU as well as on CUDA-enabled GPUs. It is available at https://github.com/fkallen/CARE .
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.